Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment

Stress urinary incontinence is a significant potential source of morbidity after radical prostatectomy or radiation therapy for prostate cancer. At present, artificial urinary sphincter remains the preferred therapeutic option. However, this technique is not free from complications. In an attempt to avoid such complications, male sling has been suggested for use in patients with mild degrees of stress incontinence.

Participants needed: 400
Trial details
Age: 18+Biological sex: MaleType: ObservationalSponsor: Fundación Instituto Valenciano de OncologíaUpdated: Aug 2, 2018Locations: 1Duration: 15 Years
Eligibility criteria

The subject has agreed to be treated with the male Incontinence surgery devices [+7]

The subject has an active urinary tract infection or active skin infection in re... [+10]

Status: Recruiting

Spanish Urological Association Registry of Patients on Active Surveillance

Description: Multicentre observational study, not randomized. Ambispective character (retro and prospective). Opened to any member of the Asociación Española de Urología (AEU), public and private medicine. Justification: Active surveillance is a strategy proposed to control the overtreatment derived from the opportunist screening in prostate cancer (PCa). Its development in our country is erratic and different in every Center. This database tries to include most of patients included in active surveillance in Spain with a few minimal inclusion criteria. Multicentre registry and follow up of the active surveillance in Spain. Hypothesis: Mortality cancer specific for PCa includible in active surveillance to 15 years is lower than 5 %.

Participants needed: 946
Trial details
Age: 18-80Biological sex: MaleType: ObservationalSponsor: Fundación Instituto Valenciano de OncologíaUpdated: Feb 12, 2018Locations: 1Duration: 15 Years
Eligibility criteria

PSA ≤ 10 ng / mL; if prostate volume> 60 cc in transrectal, ultrasound includabl... [+6]

Patient not be able to accept up with repeat biopsies [+5]